DELIVERED IN 2019-2021
LAB & cGMP SPACE DELIVERED
years combined experience
communities implementing custom life science economic development strategies across the US
Repeat Clients 2020
Repeat Clients 2021
Repeat Clients To Date 2022
"There for us"
United Therapeutics has worked with Facility Logix on a variety of projects. We return to them time and again as they possess a firm and current understanding of scientific and regulatory issues impacting our facilities and projects. They develop data and market driven recommendations that enable our real estate department to present economic justifications for our decision-making. Wherever we need help, Maryland, Virginia, North Carolina, Florida or Minnesota, the Facility Logix team is there for us.
Vice President–Corporate Real Estate, United Therapeutics
Facilty Logix was a responsive and competent agent for the work we needed to accomplish. Their proposal was accurate and detailed, the execution of their work was professional, and their desire to communicate effectively and transparently was seen from beginning of the project. We felt that they understood the scope of our work and produced a product that met our needs.
Eric Murray, Ph.D.
President, Cascadia College
In our last post we discussed the emerging market of Philadelphia and its recent life sciences boom, thanks to significant federal and increasing private sector funding, leading to increased R&D activity and commercialization opportunities. This post will discuss...
As the high cost of living and limited lab space creates challenges for crowded life science markets, there are many emerging markets nationally that present alternative options where companies can expand or relocate. One example is the Greater Philadelphia market.
In coverage of U.S. life science activity, there is often much attention paid to the dominance of life science startup and investment activity in the Boston and California markets (e.g., Silicon Valley and San Diego). Although there is still a significant gap between...